ArticleFEBS open bio2026
Purification and preparation of Marchantia polymorpha Auxin Response Factor 2 for phase separation studies.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eukaryotic cells compartmentalise to optimise their biochemistry. This occurs through membrane-surrounded compartments, but also through membraneless organelles (MLOs). Many MLOs arise from Liquid-Liquid Phase Separation (LLPS) of proteins. To investigate proteins for their capacity to phase separate, as well as what properties this results in, purified protein is required for in vitro phase separation assays. We have observed that Auxin Response Factor 2 from the common liverwort Marchantia polymorpha (MpARF2) forms nuclear assemblies in vivo. Auxin Response Factors (ARFs) are transcription factors crucial for the regulation of gene expression in response to auxin, an essential signalling molecule in plants. It is currently unclear what causes the formation of MpARF2 assemblies and how they affect the protein's function. To decipher this, we present the procedures for purifying MpARF2 and preparing it for in vitro studies. The observed MpARF2 assemblies could arise by phase separation. The properties of phase-separating proteins make their expression, purification and handling challenging; therefore, optimised procedures are required. Here, we show that the purification of soluble and monomeric full-length MpARF2, as well as (truncated) variants, is possible using a three-step purification procedure involving a protein solubility tag and buffers that suppress phase separation. We also describe the subsequent protein preparation that ensures reproducible phase separation of MpARF2 during in vitro experiments. These procedures pave the way for elucidating the phase separation properties of MpARF2 and the potential functional role of its assemblies while providing a protocol which can facilitate similar studies of other ARFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.